Article: Progression of comorbidities in youth with overweight or obesity during the COVID-19 pandemic

Background: Childhood obesity rates have continued to increase with the COVID-19 pandemic. However, data are limited on the impact of increasing obesity on associated comorbidities.

Methods: We evaluated the progression of overweight- or obesity-associated comorbidities by investigating change in laboratory results pre-COVID-19 pandemic and post-COVID-19 pandemic onset in youth with overweight or obesity. We defined progression of comorbidities based on increase in category rather than absolute change in value.

Results: HbA1c progression was seen in 19%, and LDL cholesterol progression was seen in 26%, as defined by categories. HbA1c progression and LDL cholesterol progression were significantly correlated. HbA1c and LDL cholesterol progression were significantly associated with older age and Hispanics, respectively.

Conclusion: The results indicate youths with overweight or obesity have experienced progression of comorbidities during the COVID-19 pandemic. This study emphasizes the importance of early detection of comorbidities among a high-risk pediatric population.

Citing Articles

Individual physical activity preferences of adolescents in the Czech Republic and Poland: a 14-year comparative study reflecting the gender trends and prospective responses to global lifestyle challenges.

Kudlacek M, Fromel K, Groffik D, Mitas J BMC Pediatr. 2025; 25(1):98.

PMID: 39910462 PMC: 11796026. DOI: 10.1186/s12887-024-05342-5.

References

1.

Ogden C, Fryar C, Martin C, Freedman D, Carroll M, Gu Q . Trends in Obesity Prevalence by Race and Hispanic Origin-1999-2000 to 2017-2018. JAMA. 2020; 324(12):1208-1210. PMC: 7455882. DOI: 10.1001/jama.2020.14590. View

2.

Styne D, Arslanian S, Connor E, Farooqi I, Murad M, Silverstein J . Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017; 102(3):709-757. PMC: 6283429. DOI: 10.1210/jc.2016-2573. View

3.

Woolford S, Sidell M, Li X, Else V, Young D, Resnicow K . Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic. JAMA. 2021; 326(14):1434-1436. PMC: 8511973. DOI: 10.1001/jama.2021.15036. View

4.

Dyer O . Obesity in US children increased at an unprecedented rate during the pandemic. BMJ. 2021; 374:n2332. DOI: 10.1136/bmj.n2332. View

5.

Dunton G, DO B, Wang S . Early effects of the COVID-19 pandemic on physical activity and sedentary behavior in children living in the U.S. BMC Public Health. 2020; 20(1):1351. PMC: 7472405. DOI: 10.1186/s12889-020-09429-3. View

6.

Yang S, Guo B, Ao L, Yang C, Zhang L, Zhou J . Obesity and activity patterns before and during COVID-19 lockdown among youths in China. Clin Obes. 2020; 10(6):e12416. PMC: 7646045. DOI: 10.1111/cob.12416. View

7.

Welling M, Abawi O, van den Eynde E, van Rossum E, Halberstadt J, Brandsma A . Impact of the COVID-19 Pandemic and Related Lockdown Measures on Lifestyle Behaviors and Well-Being in Children and Adolescents with Severe Obesity. Obes Facts. 2021; 15(2):186-196. PMC: 8805051. DOI: 10.1159/000520718. View

8.

Kim E, Kwon Y, Choe Y, Kim M . COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity. Sci Rep. 2021; 11(1):5494. PMC: 7943757. DOI: 10.1038/s41598-021-84766-w. View

9.

Kang H, Jeong D, Suh B, Ahn M . The Impact of the Coronavirus Disease-2019 Pandemic on Childhood Obesity and Vitamin D Status. J Korean Med Sci. 2021; 36(3):e21. PMC: 7813584. DOI: 10.3346/jkms.2021.36.e21. View

10.

Khan H . Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients. Acta Diabetol. 2007; 44(4):193-200. DOI: 10.1007/s00592-007-0003-x. View

11.

Steinberger J, Moorehead C, Katch V, Rocchini A . Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr. 1995; 126(5 Pt 1):690-5. DOI: 10.1016/s0022-3476(95)70394-2. View

Progression of Comorbidities in Youth with Overweight or Obesity During the COVID-19 Pandemic